title: Randomized Trials to Evaluate Cardiovascular Safety of Antihyperglycemic Medications: A Worthwhile Effort?
authors.affiliation: From French Alliance for Cardiovascular Clinical Trials (FACT), Paris, France (P.G.S.); Université Paris-Diderot, Paris, France (P.G.S., R.R.); INSERM U-1148, LVTS, Paris, France (P.G.S.); DHU FIRE (Fibrosis, Inflammation and Remodelling), Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S., R.R.); National Heart and Lung Institute, ICMS, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); and INSERM U-1138, Paris, France (R.R.). gabriel.steg@aphp.fr.
authors.forename: Philippe Gabriel
authors.initials: PG
authors.lastname: Steg
authors.affiliation: From French Alliance for Cardiovascular Clinical Trials (FACT), Paris, France (P.G.S.); Université Paris-Diderot, Paris, France (P.G.S., R.R.); INSERM U-1148, LVTS, Paris, France (P.G.S.); DHU FIRE (Fibrosis, Inflammation and Remodelling), Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S., R.R.); National Heart and Lung Institute, ICMS, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); and INSERM U-1138, Paris, France (R.R.).
authors.forename: Ronan
authors.initials: R
authors.lastname: Roussel
mesh_terms: D002318:Cardiovascular Diseases / Q000097:blood / Q000139:chemically induced* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy / Q000191:economics; D038321:Glycemic Index; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000191:economics; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D007004:Hypoglycemic Agents
keywords: diabetes complications; diabetes mellitus; empagliflozin; liraglutide; randomized controlled trials